Narrow Results Clear All
Search results for ""
Journal Article > Study
Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually.
Thorpe KE, Joski P, Johnston KJ. Health Aff (Millwood). 2018;37:662-669.
Infections with antibiotic-resistant organisms are increasingly common in hospitals and ambulatory care, primarily driven by overuse of antibiotics for treatment of nonbacterial illnesses. This economic analysis found that antibiotic-resistant infections have doubled in incidence since 2002, and they add approximately $1,400 to the cost of care for each patient with an antibiotic-resistant infection. The study was performed using data from the Medical Expenditure Panel Survey, which is conducted by AHRQ. This survey does not include data on institutionalized adults, such as residents of long-term care facilities. Since antibiotic-resistant infections are common in these patients, this study may actually underestimate the total economic burden of these infections. The devastating effects of an antibiotic-resistant infection for a health care practitioner were vividly illustrated in a PSNet perspective.
Journal Article > Commentary
Liu J, Kaye KS, Mercuro NJ, et al. Infect Control Hosp Epidemiol. 2019;40:206-207.
Never events are devastating to patients and indicate serious underlying organizational safety problems. This commentary suggests that there are types of inappropriate antibiotic use behaviors that should be categorized as never events, such as use of an antibiotic longer than is required. The authors believe that labeling these incidents as never events will drive development and application of prevention strategies.